acs2021finelib

Publisher

American Chemical Society

Agreement ID acs2021finelib
Agreement labeling Consortia Offset Benefit Program (COBP)
Has the agreement been disclosed and published? Yes
URL https://finelib.fi/acs-agreement/
Agreement period 01/01/2021 – 12/31/2023
Consortia / Institution FinELib consortium
Country Finland
SIZE

Approximate range of annual corresponding author publications

200
Comments on size/article output Limited publishing allowed in the hybrid and fully open access journals but the number of articles is expected to cover the consortium output
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

Cost increase
FINANCIAL SHIFT

Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

Subscriptions partly converted to OA publishing fees
RISK SHARING

How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?

If the open access articles designated for a certain year are not used completely they can be rolled over to the next year
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

Yes
Are fully open access journals covered by the agreement? Yes
OA LICENSE CC-BY mandatory
ARTICLE TYPES
Original research articles
All peer reviewed journal articles
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

More than 50%
Comments on access costs Access-related costs are not possible to separate from publishing cost
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

Yes
PERPETUAL ACCESS RIGHTS Yes
WORKFLOW ASSESSMENT Too early to assess
Request contact to the licensee contact@esac-initiative.org